Rancho Palos Verdes, CA, United States of America

Fatemeh Akbarian

This inventor holds 47 USPTO granted patents and 25 published patent applications and 14 EPO patents, primarily in Eustachian Tube Dilation. Top assignees: Acclarent, Inc., Biosense Webster (Israel) Ltd., Accalrent, Inc.. Active years: 2020-2026.

USPTO Granted Patents = 47 

% Patents Active = 97.9

 

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 60(Granted Patents)


Location History:

  • Irvine, CA (US) (2021)
  • Rancho Palos Verdes, CA (US) (2020 - 2024)

Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Eustachian Tube
Dilation Catheter
Surgical Instrument
Image Guided Surgery
Nerve Monitoring
Flexible Implant
Multi-Balloon Dilation
CT Image Correction
Navigation Control
Endoscopic Surgery
Turbinate Reduction
Suction Instrument
47 patents (USPTO):Explore Patents

Title: The Innovative Journey of Fatemeh Akbarian

Introduction: Fatemeh Akbarian, a talented inventor based in Rancho Palos Verdes, CA, has made significant contributions to the field of technology with her groundbreaking inventions.

Latest Patents: Fatemeh Akbarian holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing her diverse range of expertise and innovation.

Career Highlights: With a background in engineering and a passion for problem-solving, Fatemeh Akbarian has led successful projects that have revolutionized industries and improved the lives of many.

Collaborations: Throughout her career, Fatemeh Akbarian has collaborated with top research institutions, leading companies, and innovative startups to bring her ideas to life and make a lasting impact on society.

Conclusion: Fatemeh Akbarian's dedication to innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…